- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05899595
Effects of a Personalized Physical Training to Reduce Fatigue (OFF2HEALTH)
Effects of a Personalized Physical Training to Reduce Fatigue in Chronic Fatigue Patients: a Randomized Controlled Trial.
Chronic fatigue (CF) is a pathological fatigue over at least 6 months, without improvement after rest or sleep. In primary care, it is the major complaint in 5 to 10% of the consultations. Physical activity is an efficient therapy to help reducing this fatigue in addition to the improvement of muscular and cardiorespiratory functions. However, it remains little exploited. Yet the studies focus mainly on precise chronic pathologies with general trainings, without considering the fatigue status and reveal a large heterogeneity. Personalizing the physical training appears to be the next step in order to improve chronic fatigue patients care.
The objective of this study will be to investigate the relevance and the effects of a personalized physical training to reduce fatigue in chronic fatigue patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: David HUPIN, MD
- Phone Number: +33 (0)477127985
- Email: david.hupin@chu-st-etienne.fr
Study Contact Backup
- Name: Arnauld GARCIN, CRA
- Phone Number: +33 (0)477128286
- Email: Arnauld.Garcin@chu-st-etienne.fr
Study Locations
-
-
-
Saint-Etienne, France, 42055
- Recruiting
- Centre Hospitalier de Saint-Etienne
-
Principal Investigator:
- David HUPIN, MD
-
Sub-Investigator:
- Léonard FEASSON, MD PhD
-
Sub-Investigator:
- Clément Foschia, MD
-
Sub-Investigator:
- Philippe BOIRON, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged ≥ 18
- Men or women
- FACIT-F score ≤ 34
- Ability to walk during 10 minutes without stopping
- Ability to receive the Myocene® stimulation protocol
- Have given written consent
- Members or beneficiaries of a social security program
Exclusion Criteria:
- Contraindication to experimental procedures
- Important health issues that would compromise the participant security during the study
- Persistent atrial fibrillation or 2nd or 3rd degree atrioventricular block
- Currently participating in an other interventional study or having so in the past thirty days
- Patient is pregnant
- Patient is unable to give an informed consent
- Patient is deprived of liberty or under guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Personalized training group with the fatigue status (PERSO)
The PERSO group will perform similar exercises as the RECO group but the training load will be adapted by changing the intensity (with the same volume as RECO) depending on the fatigue scores of the week.
The aerobic fatigue score will set the load for the aerobic exercises and the muscle fatigue score for the resistance exercises.
|
Patients will be randomly assigned to the PERSO or the RECO group. Each week, fatigue status of the patients will be assessed with four evaluations:
The RECO group will perform aerobic and resistance exercises to reach the recommendations for patients with chronic pathologies, with a moderate intensity and an increasing volume. The PERSO group will perform similar exercises as the RECO group but the training load will be adapted by changing the intensity (with the same volume as RECO) depending on the fatigue scores of the week. The aerobic fatigue score will set the load for the aerobic exercises and the muscle fatigue score for the resistance exercises. |
Active Comparator: Traditional training group following the recommendations (RECO)
The RECO group will perform aerobic and resistance exercises to reach the recommendations for patients with chronic pathologies, with a moderate intensity and an increasing volume.
|
Patients will be randomly assigned to the PERSO or the RECO group. Each week, fatigue status of the patients will be assessed with four evaluations:
The RECO group will perform aerobic and resistance exercises to reach the recommendations for patients with chronic pathologies, with a moderate intensity and an increasing volume. The PERSO group will perform similar exercises as the RECO group but the training load will be adapted by changing the intensity (with the same volume as RECO) depending on the fatigue scores of the week. The aerobic fatigue score will set the load for the aerobic exercises and the muscle fatigue score for the resistance exercises. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The primary outcome is the change in the FACIT-F score obtained before and after the exercise procedure.
Time Frame: Month 1, 4
|
The FACIT-F (Functional Assessment of Chronic Illness Therapy) is a short questionnaire consisting of 13 questions which the patient answers on a scale of 0 to 4. The scores are simply added together, inverting the scale for negative sentences, to give a result out of 52 points.
The lower the score, the greater the fatigue.
|
Month 1, 4
|
Collaborators and Investigators
Investigators
- Principal Investigator: David HUPIN, MD, CHU Saint-Etienne
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23CH091
- ANSM (Other Identifier: 2024-A00286-41)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatigue Syndrome, Chronic
-
Oslo University HospitalCompletedAdolescent Chronic Fatigue SyndromeNorway
-
Shanghai University of Traditional Chinese MedicineShanghai Yueyang Integrated Medicine HospitalRecruiting
-
Ho Cheol Shin, M.D., Ph.D.Green Cross Corporation; Ajou University School of Medicine; SymyooCompletedChronic Fatigue Syndrome | Idiopathic Chronic FatigueKorea, Republic of
-
AIM ImmunoTech Inc.Available
-
King Saud UniversityCompletedChronic Fatigue Syndrome (CFS)
-
Stony Brook UniversityCompletedChronic Fatigue Syndrome | Medically Unexplained Chronic FatigueUnited States
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruitingChronic Fatigue SyndromeFrance
-
Power Life Sciences Inc.Not yet recruitingChronic Fatigue SyndromeUnited States
-
Heilongjiang Quanle Pharmaceutical Co., Ltd.Not yet recruiting
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting
Clinical Trials on Exercise protocol
-
Universidade Federal de Sao CarlosRecruiting
-
University of Texas Southwestern Medical CenterWithdrawn
-
Federal University of São PauloUnknownHeart Failure | Physical Activity | Transplant; Failure, HeartBrazil
-
University of ValenciaRecruiting
-
Orthopedic Institute, Sioux Falls, SDCompletedFull Thickness Rotator Cuff TearUnited States
-
Grupo Rehabilitacion en SaludClinica Las AmericasCompletedChronic Heart FailureColombia
-
University of CalgaryHotchkiss Brain Institute, University of CalgaryCompletedBrain Injuries, Traumatic | Post-Concussion Syndrome | Mild Traumatic Brain Injury | Concussion, BrainCanada
-
University of MalagaMinistry of Science, Innovation and Universities, SpainNot yet recruiting
-
Wageningen UniversityGelderse Vallei HospitalUnknownMagnesium Deficiency
-
Boston Medical CenterBrigham and Women's HospitalWithdrawnAdhesive Capsulitis